The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain
- PMID: 18593295
- DOI: 10.1086/589620
The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain
Abstract
Here we characterize Francisella tularensis live vaccine strain (LVS) infection in total tumor necrosis factor (TNF) knockout (KO) mice and in transgenic mice expressing only the membrane form of TNF (memTNF). MemTNF mice, but not TNF KO mice, survived low-dose, sublethal LVS infections. Splenic nitric oxide production was impaired in infected memTNF mice and was absent in infected TNF KO mice. Spleen cell production of interferon-gamma, RANTES, and monocyte chemotactic protein-1 was elevated in TNF KO mice, compared with that in WT mice, by days 4-5 after infection, along with transiently increased numbers of CCR2(+) cells, whereas memTNF mice had an intermediate phenotype. By day 6 after infection, TNF KO mice, but not memTNF mice, exhibited massive apoptosis in spleens and livers, which shortly preceded their death. Thus, memTNF partially functions to regulate chemokine expression, cell recruitment, and nitric oxide production during primary LVS infection and protects against the induction of apoptosis observed in TNF KO mice.
Similar articles
-
Differential requirements by CD4+ and CD8+ T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth.J Immunol. 2007 Dec 1;179(11):7709-19. doi: 10.4049/jimmunol.179.11.7709. J Immunol. 2007. PMID: 18025217
-
Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.J Immunol. 1994 Aug 1;153(3):1238-45. J Immunol. 1994. PMID: 8027551
-
Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection.Infect Immun. 2006 Jun;74(6):3180-9. doi: 10.1128/IAI.02004-05. Infect Immun. 2006. PMID: 16714545 Free PMC article.
-
The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines.J Leukoc Biol. 2005 Jun;77(6):893-7. doi: 10.1189/jlb.1104637. Epub 2005 Mar 9. J Leukoc Biol. 2005. PMID: 15758077 Review.
-
Francisella tularensis vaccines.FEMS Immunol Med Microbiol. 2007 Apr;49(3):315-23. doi: 10.1111/j.1574-695X.2007.00219.x. Epub 2007 Feb 22. FEMS Immunol Med Microbiol. 2007. PMID: 17316369 Review.
Cited by
-
Inflammasome-Independent NLRP3 Restriction of a Protective Early Neutrophil Response to Pulmonary Tularemia.PLoS Pathog. 2016 Dec 7;12(12):e1006059. doi: 10.1371/journal.ppat.1006059. eCollection 2016 Dec. PLoS Pathog. 2016. PMID: 27926940 Free PMC article.
-
Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages.Sci Rep. 2020 Jul 21;10(1):12023. doi: 10.1038/s41598-020-68798-2. Sci Rep. 2020. PMID: 32694562 Free PMC article.
-
Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.Clin Vaccine Immunol. 2015 Jan;22(1):119-28. doi: 10.1128/CVI.00648-14. Epub 2014 Nov 19. Clin Vaccine Immunol. 2015. PMID: 25410207 Free PMC article.
-
Immunity to Francisella.Front Microbiol. 2011 Feb 16;2:26. doi: 10.3389/fmicb.2011.00026. eCollection 2011. Front Microbiol. 2011. PMID: 21687418 Free PMC article.
-
Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis.Clin Vaccine Immunol. 2009 Jul;16(7):1025-32. doi: 10.1128/CVI.00067-09. Epub 2009 May 20. Clin Vaccine Immunol. 2009. PMID: 19458207 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials